DADerrick Chen Wee Aw

Derrick Chen Wee Aw

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Derrick Chen Wee Aw has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Closing the gender gap in human papillomavirus protection: A survey of healthcare workers

    by Jessica Weizhen Chen, Chaoyan Dong, Derrick Chen Wee Aw

    Infection with human papillomavirus (HPV) remains one of the most common sexually transmitted infections globally and is a leading cause of anogenital and oropharyngeal cancers.1 Although traditionally regarded as a women’s health issue because of its well-established association with cervical cancer and cervical screening programmes, HPV also contributes substantially to disease burden in men.2 Highly effective vaccines are available to prevent HPV infection and associated malignancies in both sexes.3 Many countries have therefore expanded vaccination programmes for HPV to include males.4 However, vaccine uptake among men remains suboptimal, and this disparity is often attributed to factors such as knowledge, perceived risk, cost, and healthcare provider recommendation.5,6

  • Open Access

    CKD-aP in focus: A comprehensive guide from recognition to relief for local practice

    by Sye Nee Tan, Boon Cheok Lai, Pei Shan Lee, Derrick Chen Wee Aw

    Introduction: Chronic kidney disease-associated pruritus (CKD-aP) affects up to 50% of dialysis patients and significantly impairs quality of life. Despite its prevalence and impact, CKD-aP remains under-recognized and undertreated in clinical practice. Methods: A narrative review was conducted using PubMed, Scopus, and Google Scholar. Studies were selected based on clinical relevance, methodological rigor, and focus on validated patient-reported outcome measures (PROMs) and therapeutic trials, particularly involving gabapentinoids and κ-opioid receptor agonists. Key topics were reviewed jointly by nephrology and dermatology specialists, who collaborated to develop a synthesized management algorithm and treatment summary table through expert discussion. Results: This interdisciplinary review provides an overview of CKD-aP pathophysiology (Figure 1) and outlines a diagnostic algorithm (Figure 2) incorporating symptom screening, exclusion of differential diagnoses, and PROM-based severity assessment. A stepwise treatment approach is presented (Figure 3), beginning with emollients, followed by gabapentinoids, and advancing to difelikefalin—the first FDA (United States), EMA (European Union) and HSA (Health Sciences Authority) of Singapore-approved treatment for moderate-to-severe CKD-aP. The review is designed as a user-friendly resource for clinicians and nurses, regardless of their specialty background. Conclusion: CKD-aP is a complex and distressing condition requiring greater awareness and multidisciplinary care. While effective therapies like difelikefalin exist, their use is limited by cost and unfamiliarity. Future priorities should include improving access, comparing available treatments, exploring alternative drug delivery routes, and integrating quality-of-life assessments into routine care.

  • Open Access

    Severe asymptomatic hypertension: Ending the urgency of “hypertensive urgency”

    by Wai Lun Moy, Derrick Chen Wee Aw

    Severe asymptomatic hypertension (historically termed “hypertensive urgency”) is common in hospital settings and is frequently overtreated. In the absence of acute target organ damage, aggressive short-term blood pressure reduction or parenteral therapy is not recommended. Many patients experience spontaneous decline in blood pressure with rest. In fact, observational studies in non-cardiac inpatients link antihypertensive intensification to increased risk of hypoperfusion to the vital organs. We present a real case illustrating harm from rapid multi-drug stacking and then review a practical approach to management. In line with the latest AHA/ACC 2025 Hypertension Guidelines, we urge all medical practitioners to retire the emotive label of “hypertensive urgency” and adopt “severe asymptomatic hypertension” which better reflects the evidence.

  • Open Access

    Generative AI in Healthcare: Insights from Health Professions Educators and Students

    by Chaoyan Dong, Derrick Chen Wee Aw, Deanna Wai Ching Lee, Siew Ching Low, Clement C. Yan

    The integration of Generative Artificial Intelligence (GenAI) into health professions education (HPE) is rapidly transforming learning environments, raising questions about its impact on teaching and learning. This mixed methods study explores clinical educators’ and undergraduate students’ perceptions and attitudes about using GenAI tools in HPE at a tertiary hospital in Singapore. Using the Technology Acceptance Model (TAM) and the Unified Theory of Acceptance and Use of Technology (UTAUT) as theoretical frameworks, we designed and administered a survey and conducted interviews to assess participants’ perceived usefulness, ease of use, and concerns related to GenAI adoption. Quantitative survey data were analyzed for frequencies and percentages, while qualitative responses underwent thematic analysis. Results showed that students demonstrated higher GenAI adoption rates (68.7%) compared to educators (38.5%), with GenAI perceived as valuable for efficiency, research, and personalized learning. However, concerns included over-reliance on GenAI, diminished critical thinking, and ethical implications. Educators emphasized the need for institutional guidelines and training to support responsible GenAI integration. Our findings suggest that while GenAI holds great potential for enhancing education, structured institutional policies and ethical oversight are crucial for its effective use. These insights contribute to the ongoing discourse on GenAI adoption in HPE.


  • Open Access

    How we implemented Continuous Interprofessional Education at a newly established public hospital in Singapore

    by Deanna W-C Lee, Chao-Yan Dong, Derrick Chen-Wee Aw

    Introduction: To promote interprofessional collaboration (IPC), our newly established hospital implemented the Continuing Interprofessional Education (CIPE) initiatives, which included a half-day workshop and 15 sessions of Grand Rounds, with the content focusing on establishing interprofessional patient-centered care pathways, policies, and ultimately to build a community of IPC. Methods: To evaluate the impact of the CIPE initiatives, 120 staff who attended at least 50% of the CIPE sessions were invited to complete the Interprofessional Attitudes Scale (IPAS). Results: 67.5% of the invited participants completed the survey. The majority of the participants answered “agree” or “strongly agree” for the domains of Teamwork/Roles/Responsibilities, Patient-centeredness, Diversity and Ethics, and Community Centeredness after going through the CIPE initiatives. The Interprofessional Bias domain revealed mixed responses. Discussions and Implications of practice: The significant contributing factors towards the success of the CIPE Grand Rounds included: (1) the topics were proposed by our staff and centered on clinical practice; (2) the delivery format was interactive, guided by adult learning principles. The mixed responses regarding the presence of biases among the participants suggested that interprofessional biases are deep-rooted in the healthcare setting, and attendance of these CIPE Grand Rounds made participants more acutely aware of these biases. However, more actions are needed to eradicate these biases.


  • Open Access

    Eczema herpeticum: A clinical diagnosis not to be missed

    by Gabriel Hong Zhe Wong, Derrick Chen Wee Aw

    Eczema herpeticum is an uncommon complication of atopic dermatitis, but often has a typical recognisable appearance. This report serves to highlight this feature in a patient who was misdiagnosed initially with a bacterial skin infection and then with a severe cutaneous drug reaction.


  • Open Access

    Tips for medical educators on how to conduct effective online teaching in times of social distancing

    by Chaoyan Dong, Deanna Wai-Ching Lee, Derrick Chen-Wee Aw

    During the current coronavirus disease 2019 pandemic, with the Singapore government mandating social distancing, all educational activities in medical schools have been affected. Medical students from our three medical schools have been banned from all clinical environments (polyclinics and hospitals). Online teaching and meetings became the norm. Although medical educators are generally good clinicians and educational tutors, many are not used to teaching and learning on an electronic platform due to various barriers such as time constraints, poor technical skills, inadequate infrastructure and a lack of institutional support. In this article, we collate tips from published work in online learning, and we also share our own experiences in conducting online teaching.


  • Open Access

    Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia

    by Marysia Tiongco Recto, Ma. Teresita Gabriel, Kanokvalai Kulthanan, Pongsakorn Tantilipikorn, Derrick Chen-Wee Aw, Tak Hong Lee, Ch’ng Chin Chwen, Somasundran Mutusamy, Nguyen Trong Hao, Vo Thanh Quang, et al.

    Allergic diseases are on the rise in many parts of the world, including the Asia–Pacific (APAC) region. Second-generation antihistamines are the first-line treatment option in the management of allergic rhinitis and urticaria. International guidelines describe the management of these conditions; however, clinicians perceive the additional need to tailor treatment according to patient profiles. This study serves as a consensus of experts from several countries in APAC (Hong Kong, Malaysia, the Philippines, Singapore, Thailand, Vietnam), which aims to describe the unmet needs, practical considerations, challenges, and key decision factors when determining optimal second-generation antihistamines for patients with allergic rhinitis and/or urticaria. Specialists from allergology, dermatology, and otorhinolaryngology were surveyed on practical considerations and key decision points when treating patients with allergic rhinitis and/or urticaria. Clinicians felt the need for additional tools for diagnosis of these diseases and a single drug with all preferred features of an antihistamine. Challenges in treatment include lack of clinician and patient awareness and compliance, financial constraints, and treatment for special patient populations such as those with concomitant disease. Selection of optimal second-generation antihistamines depends on many factors, particularly drug safety and efficacy, impact on psychomotor abilities, and sedation. Country-specific considerations include drug availability and cost-effectiveness. Survey results reveal bilastine as a preferred choice due to its high efficacy and safety, suitability for special patient populations, and the lack of sedative effects. Compliance to the international guidelines is present among allergists, dermatologists and otorhinolaryngologists; however, this is lower amongst general practitioners (GPs). To increase awareness, allergy education programs targeted at GPs and patients may be beneficial. Updates to the existing international guidelines are suggested in APAC to reflect appropriate management for different patient profiles and varying symptoms of allergic rhinitis and urticaria.


  • Open Access

    Acute Kidney Injury, Hypercalcemia, and Osteolytic Lesions: A Familiar Triad With a Rare Cause Complicated by Posterior Reversible Encephalopathy Syndrome

    by Nilesh Hanumant Pawar, Priscilla Pei Sze Chiam, Jessica Han Ying Tan, Jiashen Loh, Derrick Chen-Wee Aw, Shashidhar Baikunje